|Day's Range||32.70 - 33.46|
|52 Week Range||25.66 - 33.97|
|PE Ratio (TTM)||-131.24|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Genomic Health, Inc. Here are 5 ETFs with the largest exposure to GHDX-US. Comparing the performance and risk of Genomic Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
On Jun 19, we issued an updated research report on Redwood City, CA-based Genomic Health Inc (GHDX), a global cancer research company with a focus on advanced molecular diagnostics.
Categories: Yahoo FinanceGet free summary analysis Genomic Health, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Genomic Health, Inc. – Quest Diagnostics Incorporated, Trovagene, Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Foundation Medicine, Inc., Biocept, Inc., QIAGEN NV, NeoGenomics, Inc. and Exact ... Read more (Read more...)